NY Times / Suboxone redux

English: Suboxone tablet - both sides.

English: Suboxone tablet – both sides. (Photo credit: Wikipedia)

 

I thought I was done, but here are a couple more smart takes. Both support maintenance but appreciate the article raising awareness of important problems.

 

From The Institute Blog:

 

And as the articles (and the comment section) demonstrate, the use of buprenorphine to treat addiction and prevent substance use-related harms is messy.  Interlacing text and video, the NYT pieces illustrate those complexities skillfully.  Here are three points to keep in mind as you read:

1) Medication-assisted treatment reduces overdose deaths.

2) It is necessary and good that buprenorphine treatment is investigated and reported on.

3) Drugs are double edged.

 

From RecoverySI:

 

To sum it up briefly: Some really bad research was used to convince docs that there was an ‘emergency’ need for more potent opioids to treat chronic pain, and that when used properly, these new, more potent opioids presented little or no danger that the user would become addicted.

That turned out to be BS. Surprise.

The result: We’re in a drug epidemic with no South American cartels or Afghan drug lords to vilify. And with some elements in Big Pharma, and some docs, figuring how to get rich off it.

Right– that’s the same combo that got us here.

It’s my belief that many physicians, even the uncommonly brilliant and passionate ones, can have a major blind spot when it comes to the meds they prescribe. Somehow, they convince themselves that a medication is safe if they prescribe it.

 

It’s worth pointing out that they, also, are not making recovery arguments for maintenance.

 

 

2 Comments

Filed under Controversies, Harm Reduction, Policy, Treatment

2 responses to “NY Times / Suboxone redux

  1. Pingback: Two more defenses of Suboxone | Addiction & Recovery News

  2. Pingback: we can heal | Addiction & Recovery News